Globus Medical Shares Sold by Banque Pictet & Cie SA

Institutional investor trims position in medical device company

Apr. 3, 2026 at 8:06am

An extreme close-up of various metal components and industrial machinery, representing the sophisticated engineering and production behind Globus Medical's medical devices.The complex manufacturing processes behind Globus Medical's innovative spinal and orthopedic devices.Audubon Today

Banque Pictet & Cie SA reduced its stake in Globus Medical, Inc. (NYSE:GMED) by 34.5% in the fourth quarter, according to a regulatory filing. The firm sold 14,806 shares, leaving it with 28,121 shares worth $2.455 million at the end of the reporting period.

Why it matters

Globus Medical is a leading manufacturer of spinal and orthopedic implants and surgical instruments. Institutional investor activity in the company's stock can provide insights into market sentiment and expectations around the firm's performance and growth prospects.

The details

Banque Pictet & Cie SA, a Swiss private bank, reduced its position in Globus Medical during the fourth quarter of 2025. The firm sold 14,806 shares of the medical device company's stock, leaving it with a remaining stake of 28,121 shares valued at $2.455 million.

  • Banque Pictet & Cie SA reported the share sale in a regulatory filing for the fourth quarter of 2025.

The players

Banque Pictet & Cie SA

A Swiss private bank that previously held a position in Globus Medical, Inc.

Globus Medical, Inc.

A leading medical device company specializing in musculoskeletal solutions for spine and orthopedic applications.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Banque Pictet & Cie SA's stake in Globus Medical may signal a shift in investor sentiment or portfolio rebalancing, though the overall reasons behind the sale are not clear from the limited information provided. Continued monitoring of institutional activity and financial performance will be important to gauge the company's outlook.